Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
- PMID: 35921176
- PMCID: PMC9746836
- DOI: 10.1164/rccm.202207-1420LE
Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
Comment in
-
Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.Am J Respir Crit Care Med. 2023 Jun 1;207(11):1542-1543. doi: 10.1164/rccm.202305-0786LE. Am J Respir Crit Care Med. 2023. PMID: 37130124 Free PMC article. No abstract available.
Comment on
-
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST. Am J Respir Crit Care Med. 2022. PMID: 35486072 Free PMC article.
References
-
- Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, et al. American Thoracic Society; European Respiratory society; Japanese Respiratory Society; Latin American Thoracic Association An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med . 2015;192:e3–e19. - PubMed
-
- TIPAL - Treating People with Idiopathic Pulmonary Fibrosis with the Addition of Lansoprazole [Internet] 2022. https://www.uea.ac.uk/web/groups-and-centres/projects/tipal
-
- Khor YH, Bissell B, Ghazipura M, Herman D, Hon SM, Hossain T, et al. Antacid medication and antireflux surgery in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Ann Am Thorac Soc . 2022;19:833–844. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources